Promising early local control of malignant pleural mesothelioma following postoperative intensity modulated radiotherapy (IMRT) to the chest

Cancer Journal

Volumn 9, Issue 6, 2003, Pages 476-484

  Ahamad, Anesa ^a   Stevens, Craig W ^a,b   Smythe, W Roy ^a   Liao, Zhongxing ^a   Vaporciyan, Ara A ^a   Rice, David ^a   Walsh, Garrett ^a   Guerrero, Thomas ^a   Chang, Joe ^a   Bell, Brent ^a   Komaki, Ritsuko ^a   Forster, Kenneth M ^a  

^a Box 97 ^*

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

IMRT; Mesothelioma; Radiotherapy

Indexed keywords

ARTICLE; BREATHING MECHANICS; CANCER CONTROL; CANCER SURVIVAL; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DOSIMETRY; DYSPNEA; ESOPHAGITIS; FOLLOW UP; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LUNG SURGERY; NAUSEA; PLEURA MESOTHELIOMA; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; THORAX WALL; VOMITING; ADJUVANT THERAPY; ADULT; AGED; BRACHYTHERAPY; FEMALE; LUNG RESECTION; MALE; MESOTHELIOMA; METHODOLOGY; MIDDLE AGED; MORTALITY; PLEURA TUMOR; RADIATION DOSE; SURVIVAL; TREATMENT OUTCOME;

ADULT; AGED; BRACHYTHERAPY; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MESOTHELIOMA; MIDDLE AGED; PLEURAL NEOPLASMS; PNEUMONECTOMY; RADIOTHERAPY DOSAGE; RADIOTHERAPY, ADJUVANT; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 1842851742     PISSN: 15289117     EISSN: 1540336X     Source Type: Journal    
DOI: 10.1097/00130404-200311000-00008     Document Type: Article

References (38)

1. Intensity Modulated Radiation Therapy Collaborative Working Group. Intensity-modulated radiotherapy: current status and issues of interest. Int J Radiat Oncol Biol Phys 2001;51:880-914.
2. Rusch VW. Pleurectomy/decortication and adjuvant therapy for malignant mesothelioma. Chest 1993;103:382S-384S.
3. Gordon W, Antman KH, Greenberger JS et al. Radiation therapy in the management of patients with mesothelioma. Int J Radiat Oncol Biol Phys 1982;8:19-25.
4. Rusch VW, Piantadosi S, Holmes EC. The role of extrapleural pneumonectomy in malignant pleural mesothelioma: a Lung Cancer Study Group trial. J Thorac Cardiovasc Surg 1991;102:1-9.
5. Butchart EG, Ashcroft T, Barnsley WC et al. Pleuropneumonectomy in the management of diffuse malignant mesothelioma of the pleura: experience with 29 patients. Thorax 1976;31:15.
6. Jaklitsch MT, Grondin SC, Sugarbaker DJ. Treatment of malignant mesothelioma. World J Surg 2001;25:210-217.
7. Sugarbaker DJ, Flores RM, Jaklitsch MT et al. Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients. J Thorac Cardiovasc Surg 1999;117:54-65.
8. Huncharek M, Kelsey K, Mark EJ et al. Treatment and survival in diffuse malignant pleural mesothelioma; a study of 83 cases from the Massachusetts General Hospital. Anticancer Res 1996;16: 1265-1268.
9. Calavrezos A, Koschel G, Husselmann H et al. Malignant mesothelioma of the pleura: a prospective therapeutic study of 132 patients from 1981-1985. Klin Wochenschr 1988;66:607-613.
10. Baldini EH, Recht A, Strauss GM et al. Patterns of failure after trimodality therapy for malignant pleural mesothelioma. Ann Thorac Surg 1997;63:334-338.
11. Bricout PB, Engler MJ. Computerized tomography scanning and the planning of high dose radiotherapy for pleural mesothelioma: a report of five patients. Int J Radiat Oncol Biol Phys 1981;7: 821-826.
12. Rusch VW, Rosenzweig K, Venkatraman E et al. A phase II trial of surgical resection and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma. J Thorac Cardiovasc Surg 2001;122:788-795.
13. Kutcher GJ, Kestler C, Greenblatt D et al. Technique for external beam treatment for mesothelioma. Int J Radiat Oncol Biol Phys 1987;13:1747-1752.
14. Sugarbaker DJ, Strauss GM, Lynch TJ et al. Node status has prognostic significance in the multimodality therapy of diffuse, malignant mesothelioma. J Clin Oncol 1993;11:1172-1178.
15. Forster KM, Smythe WR, Starkschall G et al. Intensity modulated radiation therapy following extrapleural pneumonectomy for the treatment of malignant mesothelioma: clinical implementation. Int J Radiat Oncol Biol Phys 2003;55:606-616.
16. Arbuck SG, Ivy SP, Setser A et al. The Revised Common Toxicity Criteria: Version 2.0. CTEP Website, http://ctep.cancer.gov
17. Price B. Analysis of current trends in United States mesothelioma incidence. Am J Epidemiol 1997;145:211-218.
18. McDonald AD, McDonald JC. Epidemiology of malignant mesothelioma. In: Antman K, Aisner J, eds. Asbestos-Related Malignancy. Orlando: Grune & Stratton, 1987:31-55.
19. Antman KH, Corson JM. Benign and malignant pleural mesothelioma. Clin Chest Med 1985;6:127-140.
20. Lanphear BP, Buncher CR. Latent period for malignant mesothelioma of occupational origin. J Occup Environ Med 1992;34: 718-721.
21. Brollo A, Ramani L, Zuch C et al. Latency periods in asbestos-related mesothelioma of the pleura. Eur J Cancer Prev 1997;6: 162-166.
22. Pass HI, Donington JS, Wu P et al. Human mesotheliomas contain the simian virus-40 regulatory region and large tumor antigen DNA sequences. J Thorac Cardiovasc Surg 1998;116:854-859.
23. Carbone M, Rizzo P, Pass HI. Simian virus 40, poliovaccines and human tumors: a review of recent developments. Oncogene 1997; 15:1877-1888.
24. Evaluation of 63 patients with diffuse malignant mesothelioma. Proc Am Soc Clin Oncol 1980;21:360-361.
25. Law MR, Hodson ME, Turner-Warwick M. Malignant mesothelioma of the pleura: clinical aspects and symptomatic treatment. Eur Respir J Suppl 1984;65:162-168.
26. Ruffie P, Feld R, Minkin S et al. Diffuse malignant mesothelioma of the pleura in Ontario and Quebec: a retrospective study of 332 patients. J Clin Oncol 1989;7:1157-1168.
27. Rusch VW, Venkatraman ES. Important prognostic factors in patients with malignant pleural mesothelioma, managed surgically. Ann Thorac Surg 1999;68:1799-1804.
28. Pass HI, Kranda K, Temeck BK et al. Surgically debulked malignant pleural mesothelioma: results and prognostic factors. Ann Surg Oncol 1997;4:215-222.
29. Takita H, Mang TS, Loewen GM et al. Operation and intracavitary photodynamic therapy for malignant pleural mesothelioma: a phase II study. Ann Thorac Surg 1994;58:995-998.
30. Takita H, Dougherty TJ. Intracavitary photodynamic therapy for malignant pleural mesothelioma. Semin Surg Oncol 1995;11: 368-371.
31. Sauter ER, Langer C, Coia LR et al. Optimal management of malignant mesothelioma after subtotal pleurectomy: revisiting the role of intrapleural chemotherapy and postoperative radiation. J Surg Oncol 1995;60:100-105.
32. Soubra M, Dunscombe PB, Hodson DI et al. Physical aspects of external beam radiotherapy for the treatment of malignant pleural mesothelioma. Int J Radiat Oncol Biol Phys 1990;18:1521-1527.
33. Hilaris BS, Nori D, Kwong E et al. Pleurectomy and intraoperative brachytherapy and postoperative radiation in the treatment of malignant pleural mesothelioma. Int J Radiat Oncol Biol Phys 1984;10:325-331.
34. Sugarbaker DJ, Garcia JP, Richards WG et al. Extrapleural pneumonectomy in the multimodality therapy of malignant pleural mesothelioma: results in 120 consecutive patients. Ann Surg 1996;224: 288-296.
35. Rubin P, Siemann DW. Principles of radiation oncology and cancer radiotherapy. In: Rubin P, McDonald S, Qazi R, eds. Clinical Oncology: A Multidisciplinary Approach, ed 7. Philadelphia: W.B. Saunders, 1993:72.
36. Fletcher GH, Shukovsky LJ. The interplay of radiocurability and tolerance in the irradiation of human cancers. J Radiol 1975;56: 383-400.
37. Ball DL, Cruickshank DG. The treatment of malignant mesothelioma of the pleura: review of a 5-year experience, with special reference to radiotherapy. Am J Clin Oncol 1990;13:4-9.
38. Gordon W Jr, Antman KH, Greenberger JS et al. Radiation therapy in the management of patients with mesothelioma. Int J Radiat Oncol Biol Phys 1982;8:19-25.